Skip to main content

CORRECTION article

Front. Oncol., 22 August 2022
Sec. Gastrointestinal Cancers: Colorectal Cancer

Corrigendum: Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression

Ding ZhangDing Zhang1Hao HuangHao Huang1Ting ZhengTing Zheng1Lei ZhangLei Zhang1Binbin CuiBinbin Cui2Yanlong LiuYanlong Liu2Shiheng TanShiheng Tan1Liyuan ZhaoLiyuan Zhao1Tian TianTian Tian1Lijing GaoLijing Gao1Qingzhen FuQingzhen Fu1Zesong ChengZesong Cheng1Yashuang Zhao*Yashuang Zhao1*
  • 1Department of Epidemiology, School of Public Health, NHC Key Laboratory of Etiology and Epidemiology (23618504), Harbin Medical University, Harbin, China
  • 2Department of Colorectal Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, China

A corrigendum on
Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression

By Zhang D, Huang H, Zheng T, Zhang L, Cui B, Liu Y, Tan S, Zhao L, Tian T, Gao L, Fu Q, Cheng Z and Zhao Y (2022) 12:924988. doi: 10.3389/fonc.2022.924988

Error in Figure/Table

In the published article, there was an error in Figure 4 as published. The microscopy slides of migration of “Vector” group and “PIGR+ LAMB3” group were misused in Figure 4G due to carelessness. The corrected Figure 4 and its caption appear below.

FIGURE 4
www.frontiersin.org

Figure 4 PIGR suppresses AKT-FOXO3/4 axis through LAMB3 (A) Relative LAMB3 mRNA expression of empty vector (Vector), PIGR-overexpressing (PIGR), LAMB3-overexpressing (LAMB3) and rescue experiment group (PIGR & LAMB3) in RKO and HCT-8 cells. Differences compared to Vector group (n = 3; one-way ANOVA, P adjusted by FDR). (B) Cell proliferation was detected by CCK-8 assay at 0, 24, 48, 72 and 96 hours in RKO and HCT-8 cells (n = 3; one-way ANOVA, P adjusted by FDR). (C) The colony formation assay of RKO and HCT-8 cells (n = 3; one-way ANOVA, P adjusted by FDR). (D–G) Wound healing, migration, and invasion assays were performed in RKO and HCT-8 cells (n = 3; one-way ANOVA, P adjusted by FDR). (H, I) Western blot showed altered protein levels of AKT-FOXO3/4 axis in empty vector, PIGR-overexpressing, LAMB3- overexpressing and rescue experiment group in RKO and HCT-8 cells. Differences compared to Vector group. Data are presented as the mean ± S.D. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: colorectal cancer, polymeric immunoglobulin receptor, prognostic marker, AKTFOXO3/4 axis, methylation-driven gene

Citation: Zhang D, Huang H, Zheng T, Zhang L, Cui B, Liu Y, Tan S, Zhao L, Tian T, Gao L, Fu Q, Cheng Z and Zhao Y (2022) Corrigendum: Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression. Front. Oncol. 12:1012871. doi: 10.3389/fonc.2022.1012871

Received: 06 August 2022; Accepted: 08 August 2022;
Published: 22 August 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Zhang, Huang, Zheng, Zhang, Cui, Liu, Tan, Zhao, Tian, Gao, Fu, Cheng and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yashuang Zhao, zhao_yashuang@263.net

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.